Cassava Sciences Newsroom

H.C. Wainwright Upgrades Cassava Sciences(SAVA.US) to Buy Rating, Announces Target Price $116

Futu NewsOct 8 20:33

Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.

Dow JonesOct 8 20:29

Cassava Sciences Analyst Ratings

BenzingaAug 13 19:22

H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Hold Rating

Futu NewsAug 13 18:31

JonesTrading Keeps Their Hold Rating on Cassava Sciences (SAVA)

TipRanksAug 9 05:00

Rodman & Renshaw Reiterates Buy on Cassava Sciences, Maintains $107 Price Target

BenzingaAug 9 02:30

Cassava Sciences Analyst Ratings

BenzingaAug 9 02:28

Cassava Sciences Analyst Ratings

BenzingaJul 19 18:44

H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)

TipRanksJul 19 18:21

Cassava Sciences Analyst Ratings

BenzingaJul 1 19:03

Cassava Sciences (SAVA) Was Downgraded to a Hold Rating at H.C. Wainwright

TipRanksJul 1 18:19

Analysts Offer Insights on Healthcare Companies: Aroa Biosurgery Ltd (AU:ARX), Cassava Sciences (SAVA) and Amplifon S.p.A. (GB:0N61)

TipRanksMay 27 17:05

Cassava Sciences Analyst Ratings

BenzingaMay 17 20:15

Cassava Sciences Progresses in Phase 3 Trials, Secures Strong Cash Position: A Buy Rating Justified

TipRanksMay 14 04:31

Cassava Sciences Analyst Ratings

BenzingaMar 5 19:45

HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target

BenzingaMar 5 19:45

Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)

TipRanksFeb 29 03:50

Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), CymaBay Therapeutics (CBAY)

TipRanksNov 8, 2023 22:10

Analysts Offer Insights on Healthcare Companies: Cassava Sciences (SAVA), Kiora Pharmaceuticals (KPRX) and Bluebird Bio (BLUE)

TipRanksNov 8, 2023 00:31

Cassava Sciences' Simufilam Efficacy and Safety in Alzheimer's Treatment Bolsters Buy Rating: An Analysis of Trial Results and Future Projections

TipRanksOct 31, 2023 00:25